{"transactions":[{"id":732285,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":36851,"kind":"person","name":"Lebowitz Peter F","position":1,"cik":"0002121402","reported_name":"Lebowitz Peter F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-18T20:57:26.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":7289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the stock option vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting of Stockholders of the Issuer following the date of grant, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date."}],"balance_after":7289,"derivative":{"exercise_price":7.73,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":7289},"source":{"system":"sec-edgar","filing":"0001193125-26-276046","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526276046/ownership.xml","form_type":"4"}},{"id":827451,"issuer":{"id":5215,"kind":"organization","name":"BridgeBio Oncology Therapeutics, Inc.","symbol":"BBOT"},"owners":[{"id":36851,"kind":"person","name":"Lebowitz Peter F","position":1,"cik":"0002121402","reported_name":"Lebowitz Peter F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-26T21:14:24.000Z","date":"2026-03-24","kind":"grant","planned":false,"acquired":true,"shares":63350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 24, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":63350,"derivative":{"exercise_price":8.72,"expiration_date":"2036-03-23","underlying":"Common Stock","underlying_shares":63350},"source":{"system":"sec-edgar","filing":"0001193125-26-126602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869105/000119312526126602/ownership.xml","form_type":"4"}}]}